Progress Report on Neglected Tropical Disease Drug Donation Programs

Clinical Therapeutics

Volumn 38, Issue 5, 2016, Pages 1193-1204

  Cohen, Joshua P ^a   Silva, Lisseth ^b   Cohen, Alisa ^c   Awatin, Josephine ^a   Sturgeon, Robert ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c Neurotech Pharmaceuticals   (United States)

Author keywords

drug donation programs; London Declaration on Neglected Tropical Diseases; neglected tropical diseases; patient access

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B LIPID COMPLEX; AZITHROMYCIN; CITRIC ACID; CLOFAZIMINE; DAPSONE; DIETHYLCARBAMAZINE; IVERMECTIN; MEBENDAZOLE; MELARSOPROL; NIFURTIMOX; PENTAMIDINE; RIFAMPICIN; TRICLABENDAZOLE;

ARTICLE; CHAGAS DISEASE; CLINICAL ASSESSMENT; DISEASE ASSESSMENT; DRUG DONATION PROGRAM; DRUG INDUSTRY; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SURVEY; HELMINTHIASIS; HUMAN; LEISHMANIASIS; MEDLINE; NEGLECTED DISEASE; NEGLECTED TROPICAL DISEASE; PEER REVIEW; PHARMACEUTICAL CARE; PRODUCT DEVELOPMENT; RESOURCE ALLOCATION; SCHISTOSOMIASIS; TROPICAL DISEASE; HEALTH; NEGLECTED DISEASES; RESEARCH; TROPICAL MEDICINE; WORLD HEALTH ORGANIZATION;

GLOBAL HEALTH; HUMANS; NEGLECTED DISEASES; RESEARCH REPORT; TROPICAL MEDICINE; WORLD HEALTH ORGANIZATION;

EID: 84962119050     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2016.02.031     Document Type: Article

References (32)

1. World Health organization. Neglected tropical diseases. Geneva, 2014. Available at: http://www.who.int/neglected-diseases/diseases/en/. cited 2015 Sep 17.
2. P. Trouiller, P. Olliaro, E. Torreele, and et al. Drug development for neglected diseases: a deficient market and a public-health policy failure Lancet 359 2002 2188 2194
3. J. Cohen, M. Dibner, and A. Wilson Development of and access to products for neglected diseases PLoS ONE 5 2010 e10610
4. Moran M, Chapman N, Abela-Oversteegen L, et al. Neglected disease research and development: the Ebola effect. Dec 2015. Cited 2015 Dec 8. http://www.policycures.org/downloads/Y8%20GFINDER%20full%20report%20web.pdf.
5. J. Cohen, G. Sturgeon, and A. Cohen Measuring progress in neglected disease drug development Clin Ther 36 2014 1037 1042
6. Global Network Neglected Tropical Diseases. London declaration. Jan. 2012. Cited 2015 Sep 11. http://www.globalnetwork.org/london-declaration.
7. World Health Organization. London Declaration on neglected tropical diseases. Jan 2012. Cited 2015 Sep 9. http://www.who.int/neglected-diseases/London-Declaration-NTDs.pdf.
8. World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases: A roadmap for implementation. 2012. Cited 2015 Aug 21. http://whqlibdoc.who.int/hq/2012/WHO-HTM-NTD-2012.1-eng.pdf?ua=1.
9. Coyne P, Berk D. The Mectizan (ivermectin) donation program for river blindness as a paradigm for pharmaceutical industry donation programs. World Bank 2005. http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2005/08/02/000160016-20050802170313/Rendered/PDF/31570.pdf.
10. K. Leisinger Corporate responsibilities for access to medicines J Bus Ethics 85 2009 3 23
11. Novartis. Rare Disease Treatment. Cited 2015 Aug 15. https://www.novartis.com/our-work/innovation/rare-disease-treatment.
12. Novartis. Novartis Malaria Initiative. Cited 2015 Aug 31. http://malaria.novartis.com/.
13. B. Liese, M. Rosenberg, and A. Schratz Programmes, partnerships, and governance for elimination and control of neglected tropical diseases Lancet 375 2010 67 76
14. Gilead Sciences. Gilead Sciences and World Health Organization establish new five-year initiative to prevent deaths from visceral leishmaniasis. Dec 2011. Cited 2015 Aug 31. http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=1637695&highlight.
15. Nackerdien Z. Angels in medicine. Neglected tropical diseases and drug donation programs: Successes and challenges. Jul 2008. Cited 2015 Aug 9. http://www.medangel.org/drugdonate/drugdonate015.shtml#subhead3.
16. Country leadership and collaboration on neglected tropical diseases. Third progress report on the London Declaration. 2015. Cited 2015 Aug 10. http://unitingtocombatntds.org/sites/default/files/document/UTCNTD%20FULL%20REPORT.pdf.
17. World Health Organization. WHO model list of essential medicines. Apr 2015. Cited 2015 Oct 1. http://www.who.int/medicines/publications/essentialmedicines/EML2015-8-May-15.pdf.
18. Frost L, Reich M. How do good technologies get to poor people in poor countries? Cambridge, MA: Harvard University Press
19. Fehr P. Thurmann, and O. Razum Editorial: drug development for neglected diseases: a public health challenge Trop Med Int Health 11 2006 1335 1338
20. L. Conteh, T. Engels, and D. Molyneux Socioeconomic aspects of neglected tropical diseases Lancet 375 2010 239 247
21. D. Molyneux Neglected tropical diseases: now more than just 'other diseases' - the post-2015 agenda Int Health 6 2014 172 180
22. A. Fenwick, A. Gabrielli, M. French, and et al. Waterborne infectious diseases, approaches to control R.A. Meyers, Encyclopedia of Sustainability Science and Technology 2013 Springer New York
23. H.C. Turner, M. Walker, T. Churcher, and et al. Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa Clin Inf Dis 59 2014 923 932
24. B. Colatrella The Mectizan donation program: 20 years of successful collaboration - a retrospective Ann Trop Med Parasit 102 suppl 1 2008 S7 S11
25. S. Abdulla, and I. Sagara Dispersible formulation of artemether/lumefantrine: Specifically developed for infants and young children Malaria J 8 suppl 1 2009 S7 http://www.malariajournal.com/content/8/S1/S7/
26. World Health Organization. WHO model list of essential medicines for children. Mar 2011. Cited 2015 Oct 1. http://whqlibdoc.who.int/hq/2011/a95054-eng.pdf.
27. Ghana Essential Medicines List. 6th Edition. Ministry of Health Ghana National Drugs Programme. 2010. Cited 2015 Sep 29. http://apps.who.int/medicinedocs/documents/s18014en/s18014en.pdf.
28. Anti-Malaria Drug Policy for Ghana. Republic of Ghana. 2009. http://www.ghanahealthservice.org/includes/upload/publications/ANTIMALARIA%20DRUG%20POLICY.pdf.
29. Novartis and Medicines for Malaria Venture launch Coartem dispersible, The first ACT developed for children suffering from malaria. Med News Today. MediLexicon International. Jan 2009. Cited 2015 Oct 1. http://www.medicalnewstoday.com/releases/137384.php.
30. Pfizer Global Health. Lessons learned from Ghana. 2012. Cited 2015 Aug 31. http://www.pfizer.com/files/responsibility/global-health/mam-lessons-from-ghana-report.pdf.
31. N. Blanchet, G. Fink, and I. Osei-Akoto The effect of Ghana's national health insurance scheme on health care utilization Ghana Med J 46 2012 76 84
32. NTD drug supply-chain progress: Getting drugs to the countries - first-mile delivery improvements. Cited 2015 Nov 30. http://unitingtocombatntds.org/sites/default/files/drug%20supply%20chain-1.pdf.